And I think the best news here about the oral category is it's really expansionary. It's not cannibalizing Zepbound. In fact, Zepbound actually accelerated during these oral launches uh with new starts and our and our market share there.So, um I think the big concern last year from the street was how much growth could there be. Uh is this just a business where people going to cycle on and off the therapies. Is it limited by insurance.I think what we're seeing in the first half of this year and with Lily's r ...

Eli Lilly raised its 2026 sales guidance after it reported far stronger second-quarter demand than analysts estimated for its weight-loss and diabetes drugs https://t.co/YRTveVO8XX ...

Stocks are higher in the early going after the Dow and S&P 500 both closed at record highs yesterday and they have reached intraday record highs already today. The average is aiming to extend their winning streaks to 5 days. The Dow Jones Industrial Average is up 453 points at 54,538.The Nasdaq Composite with a 114 point gain and the S&P 500 jumping 48 points. Among stocks on the move this morning, SpaceX down more than 11%. Elon Musk's rocket and internet company did see its quarterly revenue nearly double ...

[music] This is Guru Focus first look, your morning market brief for Wednesday, August 5th. Here are the stories driving markets today. SpaceX shares dropped 12% after the company's first earnings report revealed significant investments in artificial intelligence, raising investor concerns about rising costs.The report highlighted that the private space firm is channeling substantial resources into AI development which has weighed on its valuation in the secondary market. The move comes as the broader techn ...

Eli Lilly reported higher net income and revenue in the recent quarter, fueled by continued surging demand for its GLP-1 weight-loss drugs. https://t.co/7EBhfBVKEe ...

CVS Health said it will revamp its weight management program through a partnership with Eli Lilly as the company lifted its full-year outlook and reported a nearly threefold increase in its second-quarter profit. https://t.co/iHsJaxbnTl ...

Good morning everybody. It is Wednesday, August the 5th. And here is what is on our agenda this morning.Tech headwinds from SpaceX CapEx and the AMD outlook. But US futures are pointing higher. Novo Nordisk obesity pill.Well they don't live up to the Wall Street height. Um Brent's below $80. As markets focus on reasons for hope around the Strait of Hormuz.It's a good vibe in the equities and futures picture this morning. Euro Stoxx 50 futures up half of a percent following the gains that we've already seen ...

I'm Jessica Edinger, CNBC. Wall Street will open Wednesday morning after a record setting rally on Tuesday on strong earnings reports and hope that the straight of hormuz will be open to oil tankers shortly. The Dow fresh record high 54,085.It was up 97 points on Tuesday, 1.7%. Cisco shares led the Dow higher. They were up 5%.The S&P 500 index adding 136 points, 1.7%. The Nasdaq soared up 671 points. That was 2 and a.5%.Most of the chip makers were higher. Intel shares were up almost 11%. The Dow and the S& ...

Hey, Kelly. So, yeah, Novo is now out with results earlier than expected. It was slated to report overnight just ahead of results from Eli Liy, but we now have Novo's full earnings release.So, Novo is raising its fullear guidance on both the top and bottom lines, not comparable to estimates due to being in constant currency, but the company is citing increased expectations for GLP1 product sales as the reason for the improved outlook. But Novo said it's expecting a sales decline within its US operations, wh ...